BMY Stock Recent News

BMY LATEST HEADLINES

BMY Stock News Image - zacks.com

Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

zacks.com 2025 Aug 22
BMY Stock News Image - youtube.com

The Investment Committee give you their top stocks to watch for the second half.

youtube.com 2025 Aug 21
BMY Stock News Image - 247wallst.com

Dividend stocks are a favorite among investors for good reason. They provide a steady income stream and offer a promising avenue for total return.

247wallst.com 2025 Aug 21
BMY Stock News Image - zacks.com

Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline expansion potential.

zacks.com 2025 Aug 20
BMY Stock News Image - zacks.com

Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com 2025 Aug 19
BMY Stock News Image - prnewswire.com

First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb's Izalontamab brengitecan (Iza-bren) based on data from the BL-B01D1-101 (CN), BL-B01D1-203 (CN), and BL-B01D1-LUNG-101 (U.S.,/EU) studies REDMOND, Wash. and PRINCETON, N.J.

prnewswire.com 2025 Aug 18
BMY Stock News Image - seekingalpha.com

The Dividend Harvesting Portfolio rebounded strongly, with profitability up 8.06% and total dividend income now at 19.77% of invested capital. I remain bullish on the S&P 500 reaching 7,000 this year, driven by strong corporate earnings, AI productivity, and a likely lower rate environment. Recent additions to the portfolio—BMY, SLB, and AGNC—reflect my focus on undervalued, high-yield opportunities poised to benefit from rate cuts.

seekingalpha.com 2025 Aug 14
BMY Stock News Image - zacks.com

Bristol Myers' Breyanzi sales surged 125% in Q2 to $344M, fueled by new approvals, strong demand and expanded market reach.

zacks.com 2025 Aug 13
BMY Stock News Image - fool.com

Investing in high-yielding dividend stocks can result in significant dividend income for your portfolio. But higher yields also tend to mean higher risk, and dividends are never guaranteed.

fool.com 2025 Aug 13
BMY Stock News Image - seekingalpha.com

Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a lineup of blockbuster drugs and a solid pipeline of drugs, an A S&P credit rating, and offers a safe and sizable yield. Rexford Industrial Realty owns high-value, mission-critical real estate, pays a well-covered dividend, and has a BBB+ S&P credit rating.

seekingalpha.com 2025 Aug 08
10 of 50